← Back to Pharma Glossary Hub
Department Technical Glossary & Q&A

HR & Plant Administration

Technical competency mapping, cGMP training administration, regulatory inspection readiness, and cross-functional SOP compliance.

Showing 85 of 85 Questions
Q1 IMPORTANT

Q1. Adsorbent in Chromatography

Solid material (such as silica gel, activated alumina, or Florisil) that holds solute molecules onto its surface through intermolecular Van der Waals or dipole forces.

Q2 IMPORTANT

Q2. Adsorption Chromatography

Chromatographic separation based on competitive physical or chemical adsorption interactions between solute molecules and active polar binding sites on the surface of a solid stationary phase (like silica or alumina).

Q3 IMPORTANT

Q3. Alpha Value (Chromatographic Selectivity)

The ratio of retention factors (k2 / k1) of two adjacent chromatographic peaks, reflecting the thermodynamic selectivity of the stationary and mobile phase system.

Q4 IMPORTANT

Q4. Anion Exchange Chromatography (AEX)

Ion-exchange mode utilizing positively charged stationary phase ligands (e.g., quaternary ammonium, Q-Sepharose) to retain negatively charged acidic proteins and DNA.

Q5 IMPORTANT

Q5. Assay of Azithromycin Dihydrate by RPHPLC

Quantitative determination of active content in dosage form using validated reversed-phase liquid chromatography. Applied specifically to Azithromycin Dihydrate.

Q6 IMPORTANT

Q6. Assay Specification & RPHPLC Method for Azithromycin Dihydrate

Validated chromatographic assay quantifying active chemical potency (typically 98.0% – 102.0% for drug substance, 95.0% – 105.0% for finished dosage). Specific to Azithromycin Dihydrate (Azalide 15-membered ring macrolide antibiotic).

Q7 IMPORTANT

Q7. Assay Specification & RPHPLC Method for Clarithromycin

Validated chromatographic assay quantifying active chemical potency (typically 98.0% – 102.0% for drug substance, 95.0% – 105.0% for finished dosage). Specific to Clarithromycin (Semisynthetic 14-membered macrolide antibiotic).

Q8 IMPORTANT

Q8. Bathochromic Shift (Red Shift)

Shift of an absorption maximum to a longer wavelength (lower energy), often caused by solvent polarity or pH changes.

Q9 IMPORTANT

Q9. Breakthrough Therapy Designation

FDA program expediting development and review of drugs for serious conditions showing substantial improvement over existing therapy.

Q10 IMPORTANT

Q10. Breakthrough Therapy Designation (FDA)

Expedited FDA development program for drugs intended to treat serious conditions where preliminary clinical evidence indicates substantial improvement over existing therapies.

Q11 IMPORTANT

Q11. BubbleThrough / Dynamic Air Lock

Cascade air lock has high pressure on one side falling to low; Sink air lock is lower pressure than both rooms; Bubble air lock is higher than both.

Q12 IMPORTANT

Q12. Chromophore

Functional group within a molecule responsible for absorbing ultraviolet or visible radiation (e.g. conjugated dienes, carbonyls, aromatics).

Q13 IMPORTANT

Q13. Circular Dichroism Spectroscopy (FarUV vs NearUV)

Spectroscopic technique measuring the differential absorption of left and right circularly polarized light: Far-UV (190-250 nm) probes secondary structure; Near-UV (250-320 nm) probes tertiary structure.

Q14 IMPORTANT

Q14. Circular Dichroism Spectroscopy (FarUV)

Spectroscopic technique measuring difference in absorption of left- and right-circularly polarized light between 190 and 260 nm.

Q15 IMPORTANT

Q15. Content Uniformity Testing of Azithromycin Dihydrate LowDose Units

Individual chemical assay of 10 separate dosage units to confirm uniform active drug substance distribution. Applied specifically to Azithromycin Dihydrate.

Q16 IMPORTANT

Q16. Content Uniformity Testing Protocol for Azithromycin Dihydrate

Harmonized USP <905> uniformity evaluation assaying 10 to 30 individual dosage units. Specific to Azithromycin Dihydrate (Azalide 15-membered ring macrolide antibiotic).

Q17 IMPORTANT

Q17. Content Uniformity Testing Protocol for Clarithromycin

Harmonized USP <905> uniformity evaluation assaying 10 to 30 individual dosage units. Specific to Clarithromycin (Semisynthetic 14-membered macrolide antibiotic).

Q18 IMPORTANT

Q18. Coulometric KF Cell Diaphragm

Porous ceramic frit separating anode and cathode compartments in coulometric Karl Fischer cells.

Q19 IMPORTANT

Q19. Critical Process Parameters (CPPs) for Azithromycin Dihydrate

Key manufacturing operating parameters (e.g. blend time, impeller RPM, compression force, drying temp) directly governing product CQAs. Specific to Azithromycin Dihydrate (Azalide 15-membered ring macrolide antibiotic).

Q20 IMPORTANT

Q20. Critical Process Parameters (CPPs) for Clarithromycin

Key manufacturing operating parameters (e.g. blend time, impeller RPM, compression force, drying temp) directly governing product CQAs. Specific to Clarithromycin (Semisynthetic 14-membered macrolide antibiotic).

Q21 IMPORTANT

Q21. Cytochrome P450 2D6 Enzyme (CYP2D6)

Polymorphic hepatic enzyme metabolizing beta-blockers, antidepressants, and activating codeine prodrug into morphine.

Q22 IMPORTANT

Q22. Cytochrome P450 3A4 Enzyme (CYP3A4)

Primary hepatic and intestinal microsomal enzyme responsible for metabolizing over 50% of commercial prescription drugs.

Q23 IMPORTANT

Q23. Cytochrome P450 CYP2D6 Genetic Polymorphism

Polymorphic drug-metabolizing enzyme displaying profound genetic variation, categorizing patients into Poor, Intermediate, Extensive, and Ultra-Rapid Metabolizers.

Q24 IMPORTANT

Q24. Cytochrome P450 CYP3A4 Isoenzyme

The most abundant phase I drug-metabolizing cytochrome P450 enzyme in human liver and intestinal mucosa, responsible for metabolizing over 50% of commercial pharmaceuticals.

Q25 IMPORTANT

Q25. Derivatization in Chromatography

Chemical modification of an analyte to enhance volatility, detectability, or chromatographic behavior.

Q26 IMPORTANT

Q26. Electron Capture Detector in Gas Chromatography

Highly selective GC detector utilizing a beta-emitting radioactive Nickel-63 (63Ni) foil to ionize carrier gas; electronegative halogen atoms capture electrons and reduce standing current.

Q27 IMPORTANT

Q27. Elemental Impurities Risk Assessment for Azithromycin Dihydrate

Formal toxicological risk assessment under ICH Q3D evaluating potential Class 1, 2A, 2B, and 3 metal contamination via ICP-MS. Specific to Azithromycin Dihydrate (Azalide 15-membered ring macrolide antibiotic).

Q28 IMPORTANT

Q28. Elemental Impurities Risk Assessment for Clarithromycin

Formal toxicological risk assessment under ICH Q3D evaluating potential Class 1, 2A, 2B, and 3 metal contamination via ICP-MS. Specific to Clarithromycin (Semisynthetic 14-membered macrolide antibiotic).

Q29 IMPORTANT

Q29. Finished Product Release Specification for Azithromycin Dihydrate

Authorized regulatory document compiling all required release tests (description, identity, assay, impurities, dissolution, microbial limits). Specific to Azithromycin Dihydrate (Azalide 15-membered ring macrolide antibiotic).

Q30 IMPORTANT

Q30. Finished Product Release Specification for Clarithromycin

Authorized regulatory document compiling all required release tests (description, identity, assay, impurities, dissolution, microbial limits). Specific to Clarithromycin (Semisynthetic 14-membered macrolide antibiotic).

Q31 IMPORTANT

Q31. Fronting Peak in Chromatography

Asymmetric chromatographic peak where the front half is broader than the rear half (Asymmetry Factor As < 0.9 or USP Tailing T < 0.9).

Q32 IMPORTANT

Q32. Gas Chromatography

Chromatography technique separating volatile compounds carried by an inert gas through a capillary column.

Q33 IMPORTANT

Q33. Gas Chromatography Mass Spectrometry

Hyphenated analytical technique coupling gas chromatographic separation with electron ionization (EI) mass spectral fragmentation and mass filtering.

Q34 IMPORTANT

Q34. Gas Chromatography Split vs Splitless Injection

Split injection vents a major fraction of vaporized sample (e.g. 1:50) to prevent column overloading; splitless injection directs the entire vaporized sample onto the column.

Q35 IMPORTANT

Q35. Gel Permeation Chromatography

Size-exclusion chromatography technique utilizing non-aqueous mobile phases to separate polymers according to their hydrodynamic volume and molecular weight distribution (Mw, Mn).

Q36 IMPORTANT

Q36. Headspace Gas Chromatography

Analytical technique where solid or liquid samples sealed in airtight vials are equilibrated at elevated temperatures, and the equilibrium vapor headspace is injected into a GC column.

Q37 IMPORTANT

Q37. Headspace Gas Chromatography Partition Coefficient

Equilibrium distribution ratio of volatile analyte concentration in sample phase (Cs) to concentration in gas headspace (Cg): K = Cs / Cg.

Q38 IMPORTANT

Q38. High Performance Liquid Chromatography

Analytical chromatography separating non-volatile liquid mixtures under high pressure through packed silica columns.

Q39 IMPORTANT

Q39. HighPerformance Liquid Chromatography Autosampler Carryover Protocol

Analytical validation test evaluating carryover by injecting blank immediately after highest calibration standard.

Q40 IMPORTANT

Q40. HighPerformance Liquid Chromatography Backpressure Fluctuation

Unexpected rise or drop in system operating pressure caused by frit clogging, column void, or air bubbles.

Q41 IMPORTANT

Q41. HighPerformance Liquid Chromatography Column Temperature Control

Precise thermostatic regulation of HPLC column compartment (typically 30-50 deg C) to maintain reproducible retention times.

Q42 IMPORTANT

Q42. HighPerformance Liquid Chromatography Detector Time Constant (Response Time)

Electronic digital filtering parameter smoothing raw optical detector signals in chromatographic software.

Q43 IMPORTANT

Q43. HighPerformance Liquid Chromatography Proportioning Valve Accuracy

Test verifying volumetric accuracy of quaternary gradient proportioning valve using acetone tracer step gradients.

Q44 IMPORTANT

Q44. HighPerformance Liquid Chromatography Pump Seal Integrity Test

Diagnostic procedure verifying high-pressure piston seal leak rate under static 300-bar pressure hold.

Q45 IMPORTANT

Q45. HighPerformance Liquid Chromatography Wavelength Linearity Verification

Evaluation of UV detector response linearity using multiple concentrations of potassium dichromate standard.

Q46 IMPORTANT

Q46. HighPerformance ThinLayer Chromatography

Sophisticated instrumental form of TLC utilizing plates with fine, uniform sorbent particle layers (5-7 um), automated sample application, and densitometric UV/fluorescence scanning.

Q47 IMPORTANT

Q47. Hydrophilic Interaction Liquid Chromatography (HILIC)

Chromatographic variant for polar analytes utilizing a hydrophilic polar stationary phase and a water-miscible organic mobile phase (high acetonitrile, low water).

Q48 IMPORTANT

Q48. Hydrophobic Interaction Chromatography

Biomolecule separation technique utilizing weakly hydrophobic stationary phases and high salt mobile phases (e.g. ammonium sulfate) that promote hydrophobic adsorption under non-denaturing conditions.

Q49 IMPORTANT

Q49. Hypsochromic Shift (Blue Shift)

Shift of an absorption maximum to a shorter wavelength (higher energy).

Q50 IMPORTANT

Q50. InProcess Controls & Sampling Frequency for Azithromycin Dihydrate

Routine tests executed during manufacturing (tablet weight variation every 15 min, hardness, thickness, friability, DT every 30 min). Specific to Azithromycin Dihydrate (Azalide 15-membered ring macrolide antibiotic).

Q51 IMPORTANT

Q51. InProcess Controls & Sampling Frequency for Clarithromycin

Routine tests executed during manufacturing (tablet weight variation every 15 min, hardness, thickness, friability, DT every 30 min). Specific to Clarithromycin (Semisynthetic 14-membered macrolide antibiotic).

Q52 IMPORTANT

Q52. IonPair ReversedPhase Chromatography

Chromatographic technique adding an amphiphilic ionic counter-ion (e.g. Sodium Heptanesulfonate for bases, Tetrabutylammonium for acids) to the mobile phase.

Q53 IMPORTANT

Q53. IonPairing Chromatography

Technique adding lipophilic ionic reagents (e.g. octane sulfonic acid, tetrabutylammonium) to retain ionic analytes on C18.

Q54 IMPORTANT

Q54. Liquid Chromatography Tandem Mass Spectrometry

Analytical powerhouse combining HPLC separation with triple-quadrupole mass spectrometry operating in Selected Reaction Monitoring (SRM/MRM) mode.

Q55 IMPORTANT

Q55. NearUV Circular Dichroism

CD spectroscopy covering 260 to 320 nm probing aromatic amino acid environments (Phe, Tyr, Trp) and disulfide bonds.

Q56 IMPORTANT

Q56. Normal Phase Liquid Chromatography

Chromatographic mode employing a polar stationary phase (silica, amino, cyano) and a non-polar organic mobile phase (hexane, heptane, isopropanol).

Q57 IMPORTANT

Q57. Protein A Affinity Chromatography

Primary downstream purification capture step binding antibody Fc region with high selectivity (> 95% purity in single step).

Q58 IMPORTANT

Q58. Related Substances & Degradation Profile for Azithromycin Dihydrate

Gradient liquid chromatographic method resolving synthesis impurities and degradation products below ICH Q3A/B qualification thresholds. Specific to Azithromycin Dihydrate (Azalide 15-membered ring macrolide antibiotic).

Q59 IMPORTANT

Q59. Related Substances & Degradation Profile for Clarithromycin

Gradient liquid chromatographic method resolving synthesis impurities and degradation products below ICH Q3A/B qualification thresholds. Specific to Clarithromycin (Semisynthetic 14-membered macrolide antibiotic).

Q60 IMPORTANT

Q60. Related Substances Testing of Azithromycin Dihydrate by Gradient HPLC

Chromatographic separation and quantitation of synthesis intermediates and degradation impurities. Applied specifically to Azithromycin Dihydrate.

Q61 IMPORTANT

Q61. Residual Solvents Limit Testing for Azithromycin Dihydrate

Headspace gas chromatography with flame ionization detection (HS-GC-FID) quantitating Class 1, 2, and 3 process solvents. Specific to Azithromycin Dihydrate (Azalide 15-membered ring macrolide antibiotic).

Q62 IMPORTANT

Q62. Residual Solvents Limit Testing for Clarithromycin

Headspace gas chromatography with flame ionization detection (HS-GC-FID) quantitating Class 1, 2, and 3 process solvents. Specific to Clarithromycin (Semisynthetic 14-membered macrolide antibiotic).

Q63 IMPORTANT

Q63. Resolution (Chromatography)

Measure of the separation between two adjacent chromatographic peaks (Rs = 2 * (tR2 – tR1) / (W1 + W2)).

Q64 IMPORTANT

Q64. Resolution Factor in Chromatography

Quantitative measure of the degree of separation between two adjacent chromatographic peaks: Rs = 2 * (tR2 – tR1) / (W1 + W2).

Q65 IMPORTANT

Q65. Reverse Phase HighPerformance Liquid Chromatography

The predominant chromatographic mode in pharma analysis, utilizing a non-polar stationary phase (C18 / C8 bonded silica) and a polar aqueous-organic mobile phase (water/buffer with acetonitrile or methanol).

Q66 IMPORTANT

Q66. ReversedPhase IonPairing Chromatography

Adding alkyl sulfonates (for bases) or tetraalkylammonium salts (for acids) to reverse phase mobile phase to retain ions.

Q67 IMPORTANT

Q67. Sanitary Diaphragm Valve (Zero Dead Leg)

Valve with PTFE diaphragm sealing directly against the weir of the process pipe, eliminating stagnant uncleaned pockets.

Q68 IMPORTANT

Q68. SignaltoNoise Ratio in Chromatography

The ratio comparing the peak height signal of an analyte to the peak-to-peak baseline background noise across a blank region of the chromatogram.

Q69 IMPORTANT

Q69. Silanol Activity in Chromatography

Presence of unreacted acidic isolated silanol groups (Si-OH) on silica surface participating in unwanted cation-exchange with amines.

Q70 IMPORTANT

Q70. Size Exclusion Chromatography

Chromatographic mode where molecules are separated strictly based on their hydrodynamic molecular size as they pass through porous gel filtration beads.

Q71 IMPORTANT

Q71. SizeExclusion Chromatography Column for Aggregates

Column packed with silica or polymer particles with calibrated pore sizes (e.g., 200 to 300 Angstroms) for protein sizing.

Q72 IMPORTANT

Q72. Snyder Chromatographic Selectivity Triangle

Classification characterizing solvent selectivity based on three dominant interaction properties: proton donor acidity (?), proton acceptor basicity (?), and dipolarity (?*).

Q73 IMPORTANT

Q73. Stability Testing of Azithromycin Dihydrate under Accelerated Conditions (40 deg C/75% RH)

Evaluation of chemical, physical, and microbiological stability under accelerated environmental stress over 6 months. Applied specifically to Azithromycin Dihydrate.

Q74 IMPORTANT

Q74. Stability Testing Protocol (ICH Q1A) for Azithromycin Dihydrate

Testing schedule (0, 3, 6, 9, 12, 18, 24, 36 months) evaluating long-term (25 deg C/60% RH) and accelerated (40 deg C/75% RH) chemical stability. Specific to Azithromycin Dihydrate (Azalide 15-membered ring macrolide antibiotic).

Q75 IMPORTANT

Q75. Stability Testing Protocol (ICH Q1A) for Clarithromycin

Testing schedule (0, 3, 6, 9, 12, 18, 24, 36 months) evaluating long-term (25 deg C/60% RH) and accelerated (40 deg C/75% RH) chemical stability. Specific to Clarithromycin (Semisynthetic 14-membered macrolide antibiotic).

Q76 IMPORTANT

Q76. Tetrahydrofuran in Chromatography

Strong organic solvent with ether oxygen conferring unique selectivity for polymer and lipid separations.

Q77 IMPORTANT

Q77. Thin Layer Chromatography Rf Value

Retention factor in planar chromatography: Rf = Distance traveled by substance / Distance traveled by solvent front.

Q78 IMPORTANT

Q78. Time Synchronization

Automatic synchronization of system internal clocks across all networked laboratory computers and instruments to a secure master network clock.

Q79 IMPORTANT

Q79. Triethylamine in Chromatography

Volatile amine additive acting as competing base to block active acidic silanol groups on older silica columns.

Q80 IMPORTANT

Q80. TwoDimensional Liquid Chromatography (2DLC)

Technique transferring fractions from first column (e.g. SEC or IEX) onto second orthogonal column (e.g. RP) via switching valve.

Q81 IMPORTANT

Q81. UltraHigh Performance Liquid Chromatography

Liquid chromatography operating at extreme fluid pressures (up to 15,000 psi / 1000 bar) utilizing sub-2-micrometer stationary phase packing particles.

Q82 IMPORTANT

Q82. USP <621> Chromatography

Compendial general chapter defining chromatographic definitions, calculations, system suitability, and allowable method adjustments.

Q83 IMPORTANT

Q83. USP <621> Chromatography Harmonization

General chapter detailing chromatographic definitions, system suitability formulas, and permissible adjustments to mobile phase, column dimensions, and flow rate without requiring revalidation.

Q84 IMPORTANT

Q84. USP Dissolution Apparatus 4 (FlowThrough Cell)

Dissolution apparatus pumping fresh or circulating dissolution medium upward through a vertical flow cell containing sample beads or tablets at controlled flow rates.

Q85 IMPORTANT

Q85. Zeta Potential Colloidal Stability Threshold

The electrokinetic potential at the slipping plane of a colloidal particle moving under an applied electric field.

×
Festive Deals Bank Discounts
Shop Now